MacroGenics, Inc. (MGNX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
29.24-2.19 (-6.97%)
At close: 4:00 PM EDT
People also watch:
FPRXXLRNKPTIEPZMXNCR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open31.35
Prev Close31.43
Bid15.12 x 100
Ask0.00 x
Day's Range29.01 - 31.95
52wk Range14.84 - 36.11
1y Target EstN/A
Market Cap1.02B
P/E Ratio (ttm)-29.60
BetaN/A
Volume211,456
Avg Vol (3m)254,168
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube16 days ago

    ETF’s with exposure to MacroGenics, Inc. : August 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to MacroGenics, Inc. Here are 5 ETF’s with the largest exposure to MGNX-US. Comparing the performance and risk of MacroGenics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • MacroGenics, Inc. :MGNX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
    Capital Cube20 days ago

    MacroGenics, Inc. :MGNX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016

    Categories: Yahoo Finance Click here to see latest analysis MacroGenics, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of MacroGenics, Inc. – Gilead Sciences, Inc., Pfizer Inc., Merck & Co., Inc., Xencor, Inc., Bristol-Myers Squibb Company, Amgen Inc. and Eli Lilly and Company (GILD-US, PFE-US, MRK-US, ... Read more (Read more...)

  • GlobeNewswire21 days ago

    MacroGenics to Participate in Two Upcoming Investor Conferences

    Rockville, MD, Aug. 04, 2016-- MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of ...